Does PIRARUBICIN Cause Second primary malignancy? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Second primary malignancy have been filed in association with PIRARUBICIN. This represents 0.6% of all adverse event reports for PIRARUBICIN.
8
Reports of Second primary malignancy with PIRARUBICIN
0.6%
of all PIRARUBICIN reports
2
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From PIRARUBICIN?
Of the 8 reports, 2 (25.0%) resulted in death.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIRARUBICIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does PIRARUBICIN Cause?
Myelosuppression (408)
White blood cell count decreased (207)
Neutrophil count decreased (145)
Bone marrow failure (127)
Nausea (111)
Vomiting (104)
Gastrointestinal disorder (58)
Leukopenia (55)
Pyrexia (55)
Neutropenia (54)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which PIRARUBICIN Alternatives Have Lower Second primary malignancy Risk?
PIRARUBICIN vs PIRFENIDONE
PIRARUBICIN vs PIRIBEDIL
PIRARUBICIN vs PIRITRAMIDE
PIRARUBICIN vs PIROXICAM
PIRARUBICIN vs PIRTOBRUTINIB